Treatment of Terminal Peritoneal Carcinomatosis by a Transducible p53-Activating Peptide

• Eric L Snyder,

  Affiliations Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Bryan R Meade,

  Affiliation Department of Cellular and Molecular Medicine, School of Medicine, University of California, San Diego, La Jolla, California, United States of America

  ⨯
• Cheryl C Saenz,

  Affiliations Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America, Department of Reproductive Medicine, School of Medicine, University of California, San Diego, La Jolla, California, United States of America

  ⨯
• Steven F Dowdy

  *To whom correspondence should be addressed. E-mail: sdowdy@ucsd.edu

  Affiliations Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America, Department of Cellular and Molecular Medicine, School of Medicine, University of California, San Diego, La Jolla, California, United States of America

  ⨯